Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase 4 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lung Neoplasms 2 Urinary Bladder Neoplasms 1 Terminal Cancer 1 Solid Tumor 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Postoperative Cognitive Complications 1 Polyps 1 Patient Satisfaction 1 Pancreatitis 1 Pancreatic Neoplasms 1 Pain, Postoperative 1 Pain 1 Mouth Neoplasms 1 Gastrointestinal Stromal Tumors 1 Fractures, Bone 1 Colonic Neoplasms 1 Choledocholithiasis 1 Choledochal Cyst 1 Cholangiocarcinoma 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Anxiety Disorders 1

Interventions

Bupivacaine 10 Saline Solution 5 Ropivacaine 5 Sodium Chloride 4 Dexmedetomidine 4 Lidocaine 3 Acetaminophen 3 Tramadol 2 Pregabalin 2 Morphine 2 Ketorolac 2 Ketamine 2 Gabapentin 2 Dexamethasone 2 Anti-Inflammatory Agents, Non-Steroidal 2 Analgesia, Epidural 2 oxycodone-acetaminophen 1 gamma-Aminobutyric Acid 1 Vitamins 1 Sufentanil 1 Spinal Puncture 1 Propofol 1 Population Groups 1 Orphenadrine 1 Neck Dissection 1 Myelography 1 MoxDuo 1 Midazolam 1 Methadone 1 Meloxicam 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Pain, Postoperative × Midazolam × Clear all

NCT06315634 2024-03-18

Intrathecal Dexmedetomidine vs Midazolame

National Cancer Institute, Egypt

Phase 4 Completed

Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡